» Articles » PMID: 38407380

A Synthetic, Closed-looped Gene Circuit for the Autonomous Regulation of RUNX2 Activity During Chondrogenesis

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2024 Feb 26
PMID 38407380
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor RUNX2 is a key regulator of chondrocyte phenotype during development, making it an ideal target for prevention of undesirable chondrocyte maturation in cartilage tissue-engineering strategies. Here, we engineered an autoregulatory gene circuit (cisCXp-shRunx2) that negatively controls RUNX2 activity in chondrogenic cells via RNA interference initiated by a tunable synthetic Col10a1-like promoter (cisCXp). The cisCXp-shRunx2 gene circuit is designed based on the observation that induced RUNX2 silencing after early chondrogenesis enhances the accumulation of cartilaginous matrix in ATDC5 cells. We show that the cisCXp-shRunx2 initiates RNAi of RUNX2 in maturing chondrocytes in response to the increasing intracellular RUNX2 activity without interfering with early chondrogenesis. The induced loss of RUNX2 activity in turn negatively regulates the gene circuit itself. Moreover, the efficacy of RUNX2 suppression from cisCXp-shRunx2 can be controlled by modifying the sensitivity of cisCXp promoter. Finally, we show the efficacy of inhibiting RUNX2 in preventing matrix loss in human mesenchymal stem cell-derived (hMSC-derived) cartilage under conditions that induce chondrocyte hypertrophic differentiation, including inflammation. Overall, our results demonstrated that the negative modulation of RUNX2 activity with our autoregulatory gene circuit enhanced matrix synthesis and resisted ECM degradation by reprogrammed MSC-derived chondrocytes in response to the microenvironment of the degenerative joint.

Citing Articles

The mechanism of curcumin protecting against IL-1β-induced oxidative stress and inflammation in chondrocytes via the Bmp2/Smad5/Runx2 pathway.

Li J, Liu W, Wang T, Wang Y, Yang G, Chen J Cytotechnology. 2025; 77(2):71.

PMID: 40028369 PMC: 11871223. DOI: 10.1007/s10616-025-00731-9.


Tibial Damage Caused by T-2 Toxin in Goslings: Bone Dysplasia, Poor Bone Quality, Hindered Chondrocyte Differentiation, and Imbalanced Bone Metabolism.

Gu W, Hou L, Bao Q, Xu Q, Chen G Animals (Basel). 2024; 14(15).

PMID: 39123807 PMC: 11311038. DOI: 10.3390/ani14152281.


A self-assembling graphene oxide coating for enhanced bactericidal and osteogenic properties of poly-ether-ether-ketone.

Huang R, Gu Y, Yuan Y, Wang Y, Pan Y, Li B Front Bioeng Biotechnol. 2024; 12:1378681.

PMID: 38774816 PMC: 11107294. DOI: 10.3389/fbioe.2024.1378681.

References
1.
Foyt D, Taheem D, Ferreira S, Norman M, Petzold J, Jell G . Hypoxia impacts human MSC response to substrate stiffness during chondrogenic differentiation. Acta Biomater. 2019; 89:73-83. PMC: 6481516. DOI: 10.1016/j.actbio.2019.03.002. View

2.
Zheng Q, Keller B, Zhou G, Napierala D, Chen Y, Zabel B . Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. J Bone Miner Res. 2008; 24(6):1022-32. PMC: 2683646. DOI: 10.1359/jbmr.081249. View

3.
Kronenberg H . Developmental regulation of the growth plate. Nature. 2003; 423(6937):332-6. DOI: 10.1038/nature01657. View

4.
Brunger J, Zutshi A, Willard V, Gersbach C, Guilak F . CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues. Arthritis Rheumatol. 2016; 69(5):1111-1121. PMC: 5406241. DOI: 10.1002/art.39982. View

5.
Takahashi N, Rieneck K, van der Kraan P, van Beuningen H, Vitters E, Bendtzen K . Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis Cartilage. 2005; 13(5):426-38. DOI: 10.1016/j.joca.2004.12.010. View